Insider trades

Fady Ibraham Malik, EVP of Cytokinetics CYTK, has filed 0 purchases and 88 sales on the open market. Over the past 12 months that comes to a net sale of $3.3M. The latest trade was on 06/23.

Fady Ibraham Malik

EVP Research & Development
First filing
23/01/12
Trades
222 trades
Buys / sales
0 / 88
12-month net buying
−$3.3M
Last trade
06/23

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2306/233,500 sh$79.51$278,285−2.2%
Open-market sale10b5-1 plan06/0906/093,500 sh$67.98$237,930−2.2%
Open-market sale10b5-1 plan05/1905/203,500 sh$75.69$264,915−2.2%
Open-market sale10b5-1 plan05/0505/053,500 sh$77.37$270,795−2.2%
Open-market sale10b5-1 plan04/2104/213,500 sh$65.69$229,915−2.2%
CYTK
Open-market sale10b5-1 plan04/0704/084,500 sh2 trades$65.11avg.$292,985−2.8%
CYTK
Open-market sale03/1703/1812,033 sh2 trades$62.15avg.$747,850.95−7.3%
Open-market sale03/0903/102,907 sh$60.72$176,513.04−2.1%
Open-market sale10b5-1 plan25/12/1625/12/162,200 sh$61.24$134,728−1.6%
Open-market sale10b5-1 plan25/12/0225/12/022,200 sh$63.89$140,558−1.5%
Open-market sale10b5-1 plan25/11/1825/11/182,200 sh$66.45$146,190−1.5%
Open-market sale10b5-1 plan25/11/0425/11/042,295 sh$59.55$136,667.25−1.6%
Open-market sale10b5-1 plan25/10/2125/10/212,105 sh$58.22$122,553.1−1.5%
Open-market sale10b5-1 plan25/10/0725/10/072,000 sh$60.56$121,120−1.4%
Open-market sale10b5-1 plan25/09/2325/09/232,000 sh$49.28$98,560−1.4%
Open-market sale10b5-1 plan25/09/0925/09/102,000 sh$51.29$102,580−1.4%
Open-market sale10b5-1 plan25/08/1925/08/192,000 sh$38.31$76,620−1.4%
Open-market sale10b5-1 plan25/08/0525/08/052,000 sh$36.34$72,680−1.4%
Open-market sale10b5-1 plan25/07/2225/07/232,000 sh$37.47$74,940−1.4%
Open-market sale10b5-1 plan25/07/0825/07/082,000 sh$33.76$67,520−1.4%